Quantbot Technologies LP

Position in NVS — Novartis AG

CIK 1512991 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,294,977

-$127,061 QoQ

Shares Held

8,263

-35.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#554

of 1,606 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Quantbot Technologies LP holds $17,451,386 across 9 Drug Manufacturers - General names. NVS ranks #6 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	128,286	$6,724,752
2	PFE	Pfizer Inc	133,304	$3,209,960
3	LLY	ELI LILLY & Co	2,129	$2,553,586
4	BMY	Bristol Myers Squibb Co	33,000	$1,901,460
5	GILD	Gilead Sciences, Inc.	11,342	$1,432,948
6	NVS	Novartis AG This page	8,263	$1,294,977
7	AZN	Astrazeneca PLC	1,009	$191,326
8	ABBV	AbbVie Inc.	464	$116,760

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,294,977	8,263	-35.2%	Shares	Sole	2026-08-12
2025-03-31	$1,422,038	12,756	-83.0%	Shares	Sole	2025-05-13
2024-12-31	$7,285,697	74,871	+87.3%	Shares	Sole	2025-02-11
2024-09-30	$4,598,039	39,976	+135.5%	Shares	Sole	2024-11-13
2024-06-30	$1,807,477	16,978	-73.1%	Shares	Sole	2024-08-09
2024-03-31	$6,103,566	63,099	+395.0%	Shares	Sole	2024-05-06
2023-12-31	$1,286,963	12,746	+304.2%	Shares	Sole	2024-02-14
2023-09-30	$321,164	3,153	+28.2%	Shares	Sole	2023-11-07
2023-06-30	$248,238	2,460	-83.2%	Shares	Sole	2023-08-08
2023-03-31	$1,348,996	14,663	-47.7%	Shares	Sole	2023-05-12
2022-03-31	$2,459,457	28,028	-34.9%	Shares	Sole	2022-05-16
2021-12-31	$3,764,009	43,032	+39.1%	Shares	Sole	2022-02-11
2021-06-30	$2,821,870	30,928	—	Shares	Sole	2021-08-12
No filing history on record for this holder in this stock.